Weekly update Companies AI-cruiter Recruiting service

Stoke Therapeutics

Stoke Therapeutics

Founded: 2014

Location: Bedford, MA

Employee range: 50 - 200

Clinical stage: Clin1/Clin2

Therapy area: Dravet syndrome (ODD)

Drug types: GEN, NEU, OPH, PED

Lead product: STK-001

Product link: https://www.stoketherapeutics.com/disease-areas/pipeline/

Funding: $97.5M stock Nov 2020; $142M IPO Jun 2019; $90M B Oct 2018; $40M A Jan 2018

stoketherapeutics.com

Short description:

Antisense Oligonucleotide Medicines

Drug notes:

STK-002 Clin1 autosomal dominant optic atrophy; undisclosed RD SYNGAP1 syndrome; undisclosed RD Rett syndrome; undisclosed RD CNS condition

Long description:

Contact us to add description.

Jobs:

Main

Recruiting service

© 2023 Work In Biotech LLC

Terms of Service

Contact: recruit@workinbiotech.com